This trial will help to assess whether the Compass Course is efficacious in helping individuals who were hospitalized with COVID-19 to reframe a sense of self and reaffirm or reconstruct a sense of purpose in their daily lives.
1 Primary · 2 Secondary · Reporting Duration: Will be assessed at baseline (week 0) and completion (following session 8, week 12)
48 Total Participants · 1 Treatment Group
Primary Treatment: Compass Course · No Placebo Group · N/A
Age 18 - 80 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: